Pharmaceuticals: Global Industry Guide

reportlinker.com/p0191852/Pharmaceuticals-Global-Industry-Guide.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

* Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of the industry

Americas accounts for 42.2% of the global pharmaceuticals market value.

Pfizer is the leading player in the global pharmaceuticals market, generating a 8.7% share of the market’s value.

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Table 1: Global pharmaceuticals market value: $ billion, 2007-11 21

Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2011 22

Table 3: Global pharmaceuticals market share: % share, by value, 2011 23

Table 4: Global pharmaceuticals market value forecast: $ billion, 2011-16 24

Table 6: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2011 35

Table 123: Pfizer Inc.: key facts 224

Table 124: Pfizer Inc.: key financials ($) 225

Table 125: Pfizer Inc.: key financial ratios 225

Table 126: GlaxoSmithKline Plc: key facts 227

Table 127: GlaxoSmithKline Plc: key financials ($) 228

Table 128: GlaxoSmithKline Plc: key financials () 229

Table 129: GlaxoSmithKline Plc: key financial ratios 229

Table 130: AstraZeneca PLC: key facts 231

Table 131: AstraZeneca PLC: key financials ($) 232

Table 132: AstraZeneca PLC: key financial ratios 233

Table 133: Merck & Co., Inc.: key facts 235

Table 134: Merck & Co., Inc.: key financials ($) 236

Table 135: Merck & Co., Inc.: key financial ratios 236

Table 136: Daiichi Sankyo Co., Ltd.: key facts 238

Table 137: Daiichi Sankyo Co., Ltd.: key financials ($) 239

Table 138: Daiichi Sankyo Co., Ltd.: key financials () 239

Table 139: Daiichi Sankyo Co., Ltd.: key financial ratios 239

Table 140: Astellas Pharma Inc.: key facts 241

Table 141: Astellas Pharma Inc.: key financials ($) 242

Table 142: Astellas Pharma Inc.: key financials () 242

Table 143: Astellas Pharma Inc.: key financial ratios 242

Table 144: Novartis AG: key facts 244

Table 145: Novartis AG: key financials ($) 245

Table 146: Novartis AG: key financial ratios 245

Table 147: Chiesi Farmaceutici S.P.A.: key facts 247

Table 148: Menarini Group, The: key facts 249

Table 149: Takeda Pharmaceutical Company Limited: key facts 250

Table 150: Takeda Pharmaceutical Company Limited: key financials ($) 251

Table 151: Takeda Pharmaceutical Company Limited: key financials () 251

Table 152: Takeda Pharmaceutical Company Limited: key financial ratios 251

Table 153: Mitsubishi Tanabe Pharma Corporation: key facts 253

Table 154: Mitsubishi Tanabe Pharma Corporation: key financials ($) 254

Table 155: Mitsubishi Tanabe Pharma Corporation: key financials () 254

Table 156: Mitsubishi Tanabe Pharma Corporation: key financial ratios 254

Table 157: Johnson & Johnson: key facts 256

Table 158: Johnson & Johnson: key financials ($) 257

Table 159: Johnson & Johnson: key financial ratios 257

Table 160: Jiangsu Yangtze River Pharmaceutical Group Company Ltd.: key facts 259

Table 161: Almirall S.A.: key facts 260

Table 162: Almirall S.A.: key financials ($) 260

Table 163: Almirall S.A.: key financials (€) 261

Table 164: Almirall S.A.: key financial ratios 261

Table 165: Sanofi: key facts 263

Table 166: Sanofi: key financials ($) 264

Table 167: Sanofi: key financials (€) 264

Table 168: Sanofi: key financial ratios 265

SOURCE Reportlinker